Aberrant microRNA expression in the development of breast carcinoma

Chinese Science Bulletin

Volumn 55, Issue 31, 2010, Pages 3517-3526

  Wu, Qian ^a,b   Li, Hai Ling ^a   Lu, Jia Feng ^a   Ge, Qing Yu ^a   Lu, Zu Hong ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

breast cancer; invasion; metastasis; microRNA; tumorigenesis

Indexed keywords

EID: 78349279557     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-010-4022-6     Document Type: Review

References (99)

1. Kloosterman W P, Plasterk R H. The diverse functions of micro-RNAs in animal development and disease. Dev Cell, 2006, 11: 441-450.
2. Stefani G, Slack F J. Small noncoding RNAs in animal development. Nat Rev Mol Cell Biol, 2008, 9: 219-230.
3. Bartel D P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 2004, 116: 281-297.
4. Gregory R I, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res, 2005, 65: 3509-3512.
5. Bentwich I. Identifying human microRNAs. Curr Top Microbiol Immunol, 2008, 320: 257-269.
6. Lewis B P, Burge C B, Bartel D P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120: 15-20.
7. Calin G A, Dumitru C D, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA, 2002, 99: 15524-15529.
8. Metzler M, Wilda M, Busch K, et al. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer, 2004, 39: 167-169.
9. Calin G A, Liu C G, Sevignani C, et al. microRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA, 2004, 101: 11755-11760.
10. Volinia S, Calin G A, Liu C G, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA, 2006, 103: 2257-2261.
11. Eder M, Scherr M. microRNA and lung cancer. N Engl J Med, 2005, 352: 2446-2448.
12. Roessler S, Budhu A, Wang X W. Future of molecular profiling of human hepatocellular carcinoma. Future Oncol, 2007, 3: 429-439.
13. Michael M Z, O'Connor S M, van Holst Pellekaan N G, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res, 2003, 1: 882-891.
14. Gregory RI, Shiekhattar R. microRNA biogenesis and cancer. Cancer Res, 2005, 65: 3509-3512.
15. Iorio M V, Visone R, Di Leva G, et al. MicroRNA signatures in human ovarian cancer. Cancer Res, 2007, 67: 8699-8707.
16. Iorio M V, Ferracin M, Liu C, et al. microRNA gene expression deregulation in human breast cancer. Cancer Res, 2005, 65: 7065-7070.
17. Mattie M D, Benz C C, Bowers J, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer, 2006, 5: 24.
18. Blenkiron C, Goldstein L D, Thorne N P, et al. microRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol, 2007, 8: R214.
19. Sempere L F, Christensen M, Silahtaroglu A, et al. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res, 2007, 67: 11612-11620.
20. Calin G A, Sevignani C, Dumitru C D, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA, 2004, 101: 2999-3004.
21. Negrini M, Rasio D, Hampton G M, et al. Definition and refinement of chromosome 11 regions of LOH in breast cancer: identification of a new region at 11q23-q24. Cancer Res, 1995, 55: 3003-3007.
22. Rasio D, Negrini M, Manenti G, et al. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions. Cancer Res, 1995, 55: 3988-3991.
23. Zhang L, Huang J, Yang N, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA, 2006, 103: 9136-9141.
24. Baylin S B. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol, 2005, 2(Suppl 1): S4-S11.
25. Lehmann U, Hasemeier B, Christgen M, et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol, 2008, 214: 17-24.
26. Lee Y S, Kim H K, Chung S, et al. Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation J Biol Chem, 2005, 280: 16635-16641.
27. Marone R, Hess D, Dankort D, et al. Memo mediates ErbB2-driven cell motility. Nat Cell Biol, 2004, 6: 515-522.
28. Seton-Rogers S E, Lu Y, Hines L M, et al. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc Natl Acad Sci USA, 2004, 101: 1257-1262.
29. Holbro T, Beerli R R, Maurer F, et al. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci USA, 2003, 100: 8933-8938.
30. Scott G K, Goga A, Bhaumik D, et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem, 2007, 282: 1479-1486.
31. Guo X, Wu Y, Hartley R S. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol, 2009, 6: 575-583.
32. Wang S, Bian C, Yang Z, et al. miR-145 inhibits breast cancer cell growth through RTKN. Int J Oncol, 2009, 34: 1461-1466.
33. Sachdeva M, Mo Y Y. microRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res, 2010, 70: 378-387.
34. Hossain A, Kuo M T, Saunders G F. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol, 2006, 26: 8191-8201.
35. Yu Z, Wang C, Wang M, et al. A cyclin D1/microRNA17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol, 2008, 182: 509-517.
36. Tsuchiya Y, Nakajima M, Takagi S, et al. microRNA regulates the expression of human cytochrome P450 1B1. Cancer Res, 2006, 66: 9090-9098.
37. Zhang J, Du Y Y, Lin Y F, et al. The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun, 2008, 377: 136-140.
38. Kenealy M R, Flouriot G, Sonntag-Buck V, et al. The 3′-untranslated region of the human estrogen receptor α gene mediates rapid messenger ribonucleic acid turnover. Endocrinology, 2000, 141: 2805-2813.
39. Adams B D, Furneaux H, White B A. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol, 2007, 21: 1132-1147.
40. Kim H K, Lee Y S, Sivaprasad U, et al. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol, 2006, 174: 677-687.
41. Kondo N, Toyama T, Sugiura H, et al. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res, 2008, 68: 5004-5008.
42. Iorio M V, Casalini P, Piovan C, et al. microRNA-205 regulates HER3 in human breast cancer. Cancer Res, 2009, 69: 2195-2200.
43. Wu H, Zhu S, Mo Y Y. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res, 2009, 19: 439-448.
44. Reinhart B J, Slack F J, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 2000, 403: 901-906.
45. Pasquinelli A E, Reinhart B J, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 2000, 408: 86-89.
46. Johnson S M, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell, 2005, 120: 635-647.
47. Akao Y, Nakagawa Y, Naoe T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull, 2006, 29: 903-906.
48. Lee Y S, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev, 2007, 21: 1025-1030.
49. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res, 2004, 64: 3753-3756.
50. Yu F, Yao H, Zhu P, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 2007, 131: 1109-1123.
51. Mertens-Talcott S U, Chintharlapalli S, Li X, et al. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res, 2007, 67: 11001-11011.
52. Guttilla I K, White B A. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem, 2009, 284: 23204-23216.
53. Chan J A, Krichevsky A M, Kosik K S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res, 2005, 65: 6029-6033.
54. Diederichs S, Haber D A. Sequence variations of microRNAs in human cancer: Alterations in predicted secondary structure do not affect processing. Cancer Res, 2006, 66: 6097-6104.
55. Roldo C, Missiaglia E, Hagan J P, et al. microRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol, 2006, 24: 4677-4684.
56. Lawrie C H, Soneji S, Marafioti T, et al. microRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer, 2007, 121: 1156-1161.
57. Calin G A, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med, 2005, 353: 1793-1801.
58. Wang T, Zhang X, Obijuru L, et al. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer, 2007, 46: 336-347.
59. Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 2007, 133: 647-658.
60. Si M L, Zhu S, Wu H, et al. miR-21-mediated tumor growth. Oncogene, 2007, 26: 2799-2803.
61. Meng F, Henson R, Lang M, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology, 2006, 130: 2113-2129.
62. Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 2007, 133: 647-658.
63. Zhu S, Si M L, Wu H, et al. microRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem, 2007, 282: 14328-14336.
64. Lu Z, Liu M, Stribinskis V, et al. microRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene, 2008, 27: 4373-4379.
65. Frankel L B, Christoffersen N R, Jacobsen A, et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem, 2008, 283: 1026-1033.
66. Mahadev K, Raval G, Bharadwaj S, et al. Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Exp Cell Res, 2002, 279: 40-51.
67. Qian B, Katsaros D, Lu L, et al. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat, 2008, 19: 19.
68. Ma L, Teruya-Feldstein J, Weinberg R A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 2007, 449: 682-688.
69. Cillo C, Cantile M, Faiella A, et al. Homeobox genes in normal and malignant cells. J Cell Physiol, 2001, 188: 161-169.
70. Carrio M, Arderiu G, Myers C, et al. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res, 2005, 65: 7177-7185.
71. Gee H E, Camps C, Buffa F M, et al. microRNA-10b and breast cancer metastasis. Nature, 2008, 455: E8-E9.
72. Huang Q, Gumireddy K, Schrier M, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol, 2008, 10: 202-210.
73. Foekens J A, Sieuwerts A M, Smid M, et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA, 2008, 105: 13021-13026.
74. Camps C, Buffa F M, Colella S, et al. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res, 2008, 14: 1340-1348.
75. Kulshreshtha R, Ferracin M, Wojcik S E, et al. A microRNA signature of hypoxia. Mol Cell Biol, 2007, 27: 1859-1867.
76. Giannakakis A, Sandaltzopoulos R, Greshock J, et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther, 2007, 7: 255-264.
77. Zhang Z, Sun H, Dai H. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle, 2009, 8: 2756-2768.
78. Van't Veer L J, Dai H, van de Vijver M J, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 2002, 415: 530-536.
79. Sotiriou C, Wirapati P, Loi S, et al. Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst, 2006, 98: 262-272.
80. Yu K, Lee C H, Tan P H, et al. A molecular signature of the Nottingham prognostic index in breast cancer. Cancer Res, 2004, 64: 2962-2968.
81. Yu J X, Sieuwerts A M, Zhang Y, et al. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer, 2007, 7: 182-195.
82. Yan L X, Huang X F, Shao Q, et al. microRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 2008, 14: 2348-2360.
83. Zhu S, Wu H, Wu F, et al. microRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res, 2008, 18: 350-359.
84. Spaderna S, Schmalhofer O, Hlubek F, et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology, 2006, 131: 830-840.
85. Aigner K, Dampier B, Descovich L, et al. The transcription factor ZEB1 (ΔEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene, 2007, 26: 6979-6988.
86. Spaderna S, Schmalhofer O, Wahlbuhl M, et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res, 2008, 68: 537-544.
87. Hurteau G J, Carlson J A, Spivack S D, et al. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res, 2007, 67: 7972-7976.
88. Burk U, Schubert J, Wellner U, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep, 2008, 9: 582-589.
89. Gregory P A, Bert A G, Paterson E L, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 2008, 10: 593-601.
90. Paterson E L, Kolesnikoff N, Gregory P A, et al. The microRNA-200 family regulates epithelial to mesenchymal transition. Scientific World J, 2008, 8: 901-904.
91. Gebeshuber C A, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep, 2009, 10: 400-405.
92. Tavazoie S F, Alarcón C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 2008, 451: 147-152.
93. Bhaumik D, Scott G K, Schokrpur S, et al. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene, 2008, 42: 5643-5647.
94. Hurst D R, Edmonds M D, Scott G K, et al. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res, 2009, 69: 1279-1283.
95. Dangi-Garimella S, Yun J, Eves E M, et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J, 2009, 28: 347-358.
96. Kong W, Yang H, He L, et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol, 2008, 28: 6773-6784.
97. Reddy S D, Ohshiro K, Rayala S K, et al. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res, 2008, 68: 8195-8200.
98. Li X F, Yan P J, Shao Z M. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene, 2009, 28: 3937-3948.
99. Valastyan S, Reinhardt F, Benaich N, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 2009, 137: 1032-1046.